| 注册
首页|期刊导航|中国药物评价|药物性肝损伤发生机制的研究进展

药物性肝损伤发生机制的研究进展

马璟婷 宋沧桑 李兴德 毛盼盼 马雪娇

中国药物评价2024,Vol.41Issue(2):132-135,4.
中国药物评价2024,Vol.41Issue(2):132-135,4.

药物性肝损伤发生机制的研究进展

Progress in the Study of the Mechanism of Drug-induced Liver Injury

马璟婷 1宋沧桑 1李兴德 1毛盼盼 2马雪娇2

作者信息

  • 1. 昆明市第一人民医院药学部,云南昆明 650000||大理大学药学院,云南大理 671000
  • 2. 昆明市第一人民医院药学部,云南昆明 650000
  • 折叠

摘要

Abstract

Drug induced liver injury(DILI)is a common adverse drug reaction worldwide and an unresolved problem in clinical prac-tice,with its incidence and lethality increasing year by year.The occurrence of DILI may be the result of a combination of factors,which have not been fully elucidated so far.In this study,we reviewed the research progress on the mechanism of drug-induced liver injury by reviewing the related literature,aiming to provide a reference for its prevention,diagnosis,and treatment in clinical science.

关键词

药物性肝损伤/发生机制/免疫反应/线粒体损伤/基因多态性/胆汁酸稳态失衡/自噬/炎症应激

Key words

Drug-induced liver injury/Mechanism/Immune response/Mitochondrial damage/Genetic polymorphism/Bile acid ho-meostatic imbalance/Autophagy/Inflammatory stress

分类

医药卫生

引用本文复制引用

马璟婷,宋沧桑,李兴德,毛盼盼,马雪娇..药物性肝损伤发生机制的研究进展[J].中国药物评价,2024,41(2):132-135,4.

基金项目

云南省临床药学中心建设项目 ()

云南省卫生健康委员会医学领军人才培养项目(L-2018012) (L-2018012)

昆明市医学科技领军人才培养项目(2023-SW-04) (2023-SW-04)

中国药物评价

2095-3593

访问量2
|
下载量0
段落导航相关论文